BCL6 and breast carcinoma: Morphometric analysis showed a significant difference (4.0% ± SE 0,3%) in Bcl6 expression in G3 breast cancer compared with G1/G2 breast cancer (1,1% ± SE 0,3%) and controls (0,50% ± SE 0,1%) (Figure 2D).